Mechanisms of Antimicrobial Resistance (AMR) and Alternative Approaches to Overcome AMR

Chew-Li Moo1, Shun-Kai Yang1, Khatijah Yusoff2

  • 1Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.

Insights

Antimicrobial resistance (AMR) is a growing threat. This review explores novel strategies like combination therapies and nanotechnology to enhance existing antimicrobials against multi-drug resistant bacteria.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Antimicrobials are crucial for combating harmful microorganisms.
  • Rising antimicrobial resistance (AMR) presents a significant global health challenge.
  • Multi-drug resistant (MDR) bacteria evolve rapidly, outpacing new drug development.

Purpose of the Study:

  • To review the causes and mechanisms of AMR.
  • To explore novel and evolving strategies for combating AMR.
  • To highlight approaches that enhance existing antimicrobial efficacy.

Main Methods:

  • Literature review of antimicrobial resistance mechanisms.
  • Analysis of current and emerging therapeutic strategies.
  • Discussion of combination therapies, bacteriophage therapy, antimicrobial adjuvants, and nanotechnology.

Main Results:

  • Discovering entirely new antimicrobial drugs is time-consuming and challenging.
  • Enhancing existing antimicrobials offers a potentially faster route to combat AMR.
  • Several innovative strategies are under evaluation to overcome resistance.

Conclusions:

  • A multi-pronged approach is needed to combat AMR effectively.
  • Enhancing current antimicrobials through novel strategies is a promising avenue.
  • Future research should focus on developing and implementing these evolving strategies.

Related Concept Videos

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
205
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.1K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.1K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
987
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
14.3K
Null and Alternative Hypotheses01:16

Null and Alternative Hypotheses

The actual hypothesis testing begins by considering two hypotheses. They are termed  the null hypothesis and the alternative hypothesis. These hypotheses contain opposing viewpoints.
The null hypothesis, denoted by H0 is a statement of no difference between the variables—they are not related. This can often be considered the status quo. As  a result if you cannot accept the null, it requires some action.
The alternative hypothesis, denoted by H1 or Ha, is a claim about the...
12.7K